BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 18508592)

  • 1. The Mnks: MAP kinase-interacting kinases (MAP kinase signal-integrating kinases).
    Buxade M; Parra-Palau JL; Proud CG
    Front Biosci; 2008 May; 13():5359-73. PubMed ID: 18508592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The N and C termini of the splice variants of the human mitogen-activated protein kinase-interacting kinase Mnk2 determine activity and localization.
    Scheper GC; Parra JL; Wilson M; Van Kollenburg B; Vertegaal AC; Han ZG; Proud CG
    Mol Cell Biol; 2003 Aug; 23(16):5692-705. PubMed ID: 12897141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deeping in the Role of the MAP-Kinases Interacting Kinases (MNKs) in Cancer.
    Pinto-Díez C; Ferreras-Martín R; Carrión-Marchante R; González VM; Martín ME
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of mammalian target of rapamycin induces phosphatidylinositol 3-kinase-dependent and Mnk-mediated eukaryotic translation initiation factor 4E phosphorylation.
    Wang X; Yue P; Chan CB; Ye K; Ueda T; Watanabe-Fukunaga R; Fukunaga R; Fu H; Khuri FR; Sun SY
    Mol Cell Biol; 2007 Nov; 27(21):7405-13. PubMed ID: 17724079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mnks, eIF4E phosphorylation and cancer.
    Proud CG
    Biochim Biophys Acta; 2015 Jul; 1849(7):766-73. PubMed ID: 25450520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the activity of human MAP kinase-interacting kinase Mnk1b.
    O'Loghlen A; González VM; Jurado T; Salinas M; Martín ME
    Biochim Biophys Acta; 2007 Sep; 1773(9):1416-27. PubMed ID: 17590453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMP-activated Protein Kinase Up-regulates Mitogen-activated Protein (MAP) Kinase-interacting Serine/Threonine Kinase 1a-dependent Phosphorylation of Eukaryotic Translation Initiation Factor 4E.
    Zhu X; Dahlmans V; Thali R; Preisinger C; Viollet B; Voncken JW; Neumann D
    J Biol Chem; 2016 Aug; 291(33):17020-7. PubMed ID: 27413184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapamycin enhances eIF4E phosphorylation by activating MAP kinase-interacting kinase 2a (Mnk2a).
    Stead RL; Proud CG
    FEBS Lett; 2013 Aug; 587(16):2623-8. PubMed ID: 23831578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MAP kinase-interacting kinases regulate cell migration, vimentin expression and eIF4E/CYFIP1 binding.
    Beggs JE; Tian S; Jones GG; Xie J; Iadevaia V; Jenei V; Thomas G; Proud CG
    Biochem J; 2015 Apr; 467(1):63-76. PubMed ID: 25588502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MAP kinase-interacting kinases (MNKs) as targets in oncology.
    Xie J; Merrett JE; Jensen KB; Proud CG
    Expert Opin Ther Targets; 2019 Mar; 23(3):187-199. PubMed ID: 30650992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The C-terminal domain of Mnk1a plays a dual role in tightly regulating its activity.
    Goto S; Yao Z; Proud CG
    Biochem J; 2009 Sep; 423(2):279-90. PubMed ID: 19650764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MAP kinase-interacting kinases--emerging targets against cancer.
    Diab S; Kumarasiri M; Yu M; Teo T; Proud C; Milne R; Wang S
    Chem Biol; 2014 Apr; 21(4):441-452. PubMed ID: 24613018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic inhibition of MAP kinase interacting kinase blocks eukaryotic initiation factor 4E phosphorylation and suppresses outgrowth of experimental lung metastases.
    Konicek BW; Stephens JR; McNulty AM; Robichaud N; Peery RB; Dumstorf CA; Dowless MS; Iversen PW; Parsons S; Ellis KE; McCann DJ; Pelletier J; Furic L; Yingling JM; Stancato LF; Sonenberg N; Graff JR
    Cancer Res; 2011 Mar; 71(5):1849-57. PubMed ID: 21233335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FLI1 promotes protein translation via the transcriptional regulation of MKNK1 expression.
    Wang C; Song J; Liu W; Yao Y; Kapranov P; Sample KM; Gajendran B; Zacksenhaus E; Hao X; Ben-David Y
    Int J Oncol; 2020 Feb; 56(2):430-438. PubMed ID: 31894299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First MNKs degrading agents block phosphorylation of eIF4E, induce apoptosis, inhibit cell growth, migration and invasion in triple negative and Her2-overexpressing breast cancer cell lines.
    Ramalingam S; Gediya L; Kwegyir-Afful AK; Ramamurthy VP; Purushottamachar P; Mbatia H; Njar VC
    Oncotarget; 2014 Jan; 5(2):530-43. PubMed ID: 24504069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MNK1 and MNK2 Expression in the Human Dorsal Root and Trigeminal Ganglion.
    Shiers S; Sahn JJ; Price TJ
    Neuroscience; 2023 Apr; 515():96-107. PubMed ID: 36764601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of eIF4E by MNKs supports protein synthesis, cell cycle progression and proliferation in prostate cancer cells.
    Bianchini A; Loiarro M; Bielli P; Busà R; Paronetto MP; Loreni F; Geremia R; Sette C
    Carcinogenesis; 2008 Dec; 29(12):2279-88. PubMed ID: 18809972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MNKs act as a regulatory switch for eIF4E1 and eIF4E3 driven mRNA translation in DLBCL.
    Landon AL; Muniandy PA; Shetty AC; Lehrmann E; Volpon L; Houng S; Zhang Y; Dai B; Peroutka R; Mazan-Mamczarz K; Steinhardt J; Mahurkar A; Becker KG; Borden KL; Gartenhaus RB
    Nat Commun; 2014 Nov; 5():5413. PubMed ID: 25403230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2.
    Waskiewicz AJ; Flynn A; Proud CG; Cooper JA
    EMBO J; 1997 Apr; 16(8):1909-20. PubMed ID: 9155017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MNK-1/eIF4E pathway as a new therapeutic pathway to target inflammation and remodelling in asthma.
    Seidel P; Sun Q; Costa L; Lardinois D; Tamm M; Roth M
    Cell Signal; 2016 Oct; 28(10):1555-62. PubMed ID: 27418099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.